Biomarker for HBV therapy discontinuation

被引：1
|
作者：
Dickson, Iain
机构：
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 15卷 / 03期
关键词：
D O I：
10.1038/nrgastro.2018.6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [1] Biomarker for HBV therapy discontinuation
    Iain Dickson
    Nature Reviews Gastroenterology & Hepatology, 2018, 15 : 132 - 132
  • [2] Acute Liver Failure Due to Discontinuation of Hepatitis B Virus (HBV) Therapy
    Sunkara, Pranit R.
    Weise, Kelly
    Jafri, Syed-Mohammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2355 - S2356
  • [3] HBV Infection: Anti-HBc Levels predict Recurrence after Discontinuation of Therapy
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (05): : 554 - 554
  • [4] DISCONTINUATION OF THERAPY
    不详
    JOURNAL OF INFUSION NURSING, 2006, 29 : S58 - S58
  • [5] HBIg Discontinuation with Maintenance Oral Anti-viral Therapy and HBV Vaccination in Liver Transplant Recipients
    Nicholas K. Weber
    Lisa M. Forman
    James F. Trotter
    Digestive Diseases and Sciences, 2010, 55 : 505 - 509
  • [6] HBIg Discontinuation with Maintenance Oral Anti-viral Therapy and HBV Vaccination in Liver Transplant Recipients
    Weber, Nicholas K.
    Forman, Lisa M.
    Trotter, James F.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) : 505 - 509
  • [7] AN IMMUNOLOGICAL BIOMARKER TO PREDICT HEPATIC FLARES UPON NUC THERAPY DISCONTINUATION IN CHRONIC HEPATITIS B
    Rivino, L.
    Le Bert, N.
    Gill, U.
    Cheng, Y.
    Kunasegaran, K.
    Tan, D.
    Koh, S.
    Hansi, N.
    Foster, G.
    Newell, E.
    Kennedy, P.
    Bertoletti, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S164 - S165
  • [8] Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
    Satoshi Yamaga
    Shinichiro Ohshimo
    Nobuaki Shime
    Saad Nseir
    Boualem Sendid
    Anahita Rouzé
    Intensive Care Medicine, 2018, 44 : 399 - 400
  • [9] Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
    Yamaga, Satoshi
    Ohshimo, Shinichiro
    Shime, Nobuaki
    Nseir, Saad
    Sendid, Boualem
    Rouze, Anahita
    INTENSIVE CARE MEDICINE, 2018, 44 (03) : 399 - 400
  • [10] DISCONTINUATION OF ANTICOAGULANT THERAPY
    DUCKERT, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (10) : 390 - 390
12345